Basics Immunocore Holdings IPO Date: February 5, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.77B Activated in VL: True Average Daily Range Avg Daily Range: $1.06 | 2.53% Avg Daily Range (30 D): $0.59 | 1.72% Avg Daily Range (90 D): $0.71 | 2.28% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): .33M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 1,646 Avg Inst. Trade: $1.8M Avg Inst. Trade (30 D): $1.5M Avg Inst. Trade (90 D): $1.77M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $1.11M Avg Closing Trade (90 D): $1.02M Avg Closing Volume: 33.49K     News Mar 10, 2025 @ 7:00 PM Immunocore presents initial multiple ascending dos... Source: N/A Mar 6, 2025 @ 6:00 PM TCR Therapy Clinical Trial Pipeline Accelerates as... Source: Delveinsight Jan 6, 2025 @ 12:00 PM Immunocore to present at the 43rd Annual J.P. Morg... Source: N/A Jan 2, 2025 @ 12:00 PM Immunocore appoints Travis Coy, previously a Non-E... Source: N/A Dec 23, 2024 @ 12:00 PM Immunocore announces first patient dosed in the Ph... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.43 $.1 $-.47 Diluted EPS $-.43 $.1 $-.47 Revenue $ 333.58M $ 93.88M $ 84.05M Gross Profit $ 330.27M $ 93.05M $ 83.72M Net Income / Loss $ -21.63M $ 5.02M $ -23.77M Operating Income / Loss $ -47.59M $ -3.62M $ -19.45M Cost of Revenue $ 3.32M $ .83M $ .33M Net Cash Flow $ -355.98M $ 21.11M $ -82.04M PE Ratio